June 3, 2009 / 9:01 PM / 10 years ago

Experimental J&J drug works in resistant TB -study

BOSTON, June 3 (Reuters) - Johnson & Johnson’s (JNJ.N) experimental drug designed to starve the bacteria responsible for tuberculosis is five times more effective than older drugs at treating people with drug-resistant TB, doctors reported on Wednesday.

The company-run study found that the drug TMC207, if added to a standard cocktail of five other TB medicines, cleared traces of the tuberculosis bacteria in the sputum of 48 percent of the volunteers after eight weeks. Only 9 percent of placebo recipients showed that type of improvement.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below